2-(4-morpholinoanilino)-6-cyclohexylaminopurine,
reversine,
Reversine,
656820-32-5,
2-(4-Morpholinoanilino)-6-cyclohexylaminopurine,
UNII-Z499CLJ023,
CHEMBL188343,
CHEBI:70723,
ZFLJHSQHILSNCM-UHFFFAOYSA-N,
Z499CLJ023,
N~6~-Cyclohexyl-N~2~-(4-Morpholin-4-Ylphenyl)-9h-Purine-2,6-Diamine,
IN1127,
MFCD07784513,
9H-Purine-2,6-diamine,N6-cyclohexyl-N2-[4-(4-morpholinyl)phenyl]-,
C21H27N7O,
N6-cyclohexyl-N2-(4-morpholinophenyl)-7H-purine-2,6-diamine,
N6-cyclohexyl-N2-(4-morpholinophenyl)-9H-purine-2,6-diamine,
N(6)-cyclohexyl-N(2)-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine,
2vgo,
Reversine(HPLC),
AD5,
AC1L4OI2,
AC1Q4YB4,
MLS006010275,
SCHEMBL1800790,
DTXSID8041113,
CTK5C2989,
AOB2691,
EX-A268,
QCR-284,
HMS3229N05,
BCP07534,
ZINC3620786,
2026AH,
2682AH,
BDBM50170831,
HSCI1_000387,
N6-Cyclohexyl-N2-[4-(4-morpholinyl)phenyl]-1H-purine-2,6-diamine,
s7588,
Reversine, >=98% (HPLC), solid,
AKOS026750224,
CS-1523,
DB07340,
SB19558,
KS-00000T53,
NCGC00165880-01,
NCGC00165880-02,
NCGC00165880-03,
NCGC00165880-04,
NCGC00165880-05,
4CA-1086,
AK174897,
BC600538,
DA-41767,
HY-14711,
SC-96585,
SMR004701345,
RT-015399,
FT-0699831,
A13250,
W-5424,
2-(4-morpholinoanilino)-6-cyclohexylamino-purine,
BRD-K77286328-001-01-1,
N6-cyclohexyl-N2-(4-morpholinophenyl)-1H-purine-2,6-diamine,
1H-Purine-2,6-diamine, N6-cyclohexyl-N2-(4-(4-morpholinyl)phenyl)-,
6-N-cyclohexyl-2-N-(4-morpholin-4-ylphenyl)-7H-purine-2,6-diamine,
6-N-cyclohexyl-2-N-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine,
N*6*-Cyclohexyl-N*2*-(4-morpholin-4-yl-phenyl)-9H-purine-2,6-diamine,
N6-cyclohexyl-N2-[4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine,
D00JMT,
AR-1C8053,
C21-H27-N7-O,
CID210332,
ACN-029572,
A3760,
2-(4-MORPHOLINOANILINO)-6-CYCLOHEXYLAMINOPURINEREVERSINE,
9H-Purine-2,6-diamine, N6-cyclohexyl-N2-[4-(4-morpholinyl)phenyl]-,
7374-80-3,